Re: Amendment to Base Warrants (2016)Letter Agreement • August 5th, 2015 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
This letter agreement (this “Amendment”) amends the letter agreement in respect of the Base Warrants (2016), between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Gilead Sciences, Inc. (“Company”), dated July 26, 2010 (such letter agreement, the “Base Warrant Confirmation” and the “Transaction” as defined therein, the “Warrant Transaction”). Any capitalized term used but not defined herein shall have the meaning assigned thereto in the Base Warrant Confirmation.
THIRD AMENDMENT (REVISED) TO LICENSE AGREEMENTLicense Agreement • August 5th, 2015 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
THIS THIRD AMENDMENT (REVISED) (this “Amendment”) is made and entered into as of June 10, 2015 by and between JAPAN TOBACCO INC., a Japanese corporation having its principal place of business at JT Building, 2-1 Toranomon, 2-chome, Minato-ku, Tokyo 105-8422, Japan (“JT”), and GILEAD SCIENCES, INC., a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, CA 94404, United States (“Gilead”) and replaces that certain Third Amendment entered into between JT and Gilead dated July 5, 2011. JT and Gilead are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
